$ARCT News Article - Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR(TM) mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern
https://marketwirenews.com/news-releases/arct...44494.html